1) 日本産科婦人科学会・日本病理学会編 : 絨毛性疾患取扱い規約,改訂第2版.金原出版,東京,1995
2) 友田 豊,後藤節子 : 絨毛性疾患の診断と治療.永井書店,大阪,1996
3) FIGO Oncology Committee : FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol Obstet 77 : 285─287, 2002
4) Lurain JR : Treatment of gestational trophoblastic tumors. Curr Treat Options Oncol 3 : 113─124, 2002
5) McNeish IA, Strickland S, Holden L, et al : Low─risk persistent gestational trophoblastic disease : outcome after initial treatment with low─dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 20 : 1838─1844, 2002
6) Khan F, Everard J, Ahmed S, et al : Low─risk persistent gestational trophoblastic disease treated with low─dose methotrexate : efficacy, acute and long─term effects. Br J Cancer 89 : 2197─2201, 2003
7) Foulmann K, Guastalla JP, Caminet N et al : What is the best protocol of single─agent methotrexate chemotherapy in nonmetastatic or low─risk metastatic gestational trophoblastic tumors? A review of the evidence. Gynecol Oncol 102 : 103─110, 2006
8) Papadopoulos AJ, Foskett M, Seckl MJ, et al : Twenty─five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med 47 : 460─464, 2002
9) Bower M, Newlands ES, Holden L, et al : EMA/CO for high─risk gestational trophoblastic tumors : results from a cohort of 272 patients. J Clin Oncol 15 : 2636─2643, 1997
10) Lurain JR : Management of high─risk gestational trophoblastic disease. J Reprod Med 43 : 44─52, 1998
11) Dobson LS, Lorigan PC, Coleman RE, et al : Persistent gestational trophoblastic disease : results of MEA(methotrexate, etoposide and dactinomycin)as first─line chemotherapy in high risk disease and EA(etoposide and dactinomycin)as second─line therapy for low risk disease. Br J Cancer 82 : 1547─1552, 2000
12) Matsui H, Suzuka K, Iitsuka Y, et al : Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high─risk gestational trophoblastic tumors. Gynecol Oncol 78 : 28─31, 2000
13) 城所久美子,井箟一彦,山本英子,他 : 絨毛癌に対するModified MEA療法の検討.東海産科婦人科学会雑誌43 : 193─197,2006
14) Newlands ES, Mulholland PJ, Holden L, et al : Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D(EMA)chemotherapy for patients with high─risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 18 : 854─859, 2000
15) Matsui H, Suzuka K, Iitsuka Y, et al : Salvage combination chemotherapy with 5─fluorouracil and actinomycin D for patients with refractory, high─risk gestational trophoblastic tumors. Cancer 95 : 1051─1054, 2002
16) 野村誠二,水谷栄彦 : カレントレヴュー絨毛性疾患の現況.日本産科婦人科学会雑誌53 : 1317─1326, 2001
17) Osborne R, Covens A, Mirchandani D, et al : Successful salvage of relapsed high─risk gestational trophoblastic neoplasia patients using a novel paclitaxel─containing doublet. J Reprod Med 49 : 655─661, 2004
18) Khanlian SA, Cole LA : Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin. J Reprod Med 51 : 812─818, 2006